Publication | Closed Access
Impact of GeneXpert MTB/RIF on Patients and Tuberculosis Programs in a Low-Burden Setting. A Hypothetical Trial
42
Citations
29
References
2014
Year
Xpert could greatly reduce the frequency and impact of unnecessary empiric treatment, contact investigation, and housing, providing substantial patient and programmatic benefits if used in management decisions.
| Year | Citations | |
|---|---|---|
Page 1
Page 1